Philips to cut 4K jobs worldwide amid falling sales
Health care technology company Royal Philips NV employs roughly 80,000 employees. Philips chief executive Roy Jakobs called the job cuts "difficult, but necessary."
Tomas Philipson: Health care policy is 'most damaging' issue not discussed by economists
Former Acting Council of Economic Advisers Chair Tomas Philipson and Breitbart economics and finance editor John Carney argue Biden's agenda is shrinking U.S. economic growth.
Pfizer says it's eyeing a $110 to $130 list price for COVID-19 vaccine in U.S.
Pfizer Inc. on Thursday revealed the possible U.S. list price it is eyeing for its adult COVID-19 vaccine doses once the shot hits the commercial market.
Diabetes-related weight loss drugs facing supply issues amid viral trend
Novo Nordisk, which manufactures the antidiabetic drugs Ozempic and Wegovy, told FOX Business it's facing supply issues due to "unprecedented demand" on top of global supply constraints.
German tapped to lead Japan's medical company Olympus as CEO
Known for 35mm film cameras, Olympus now focuses on more advanced cameras, the kinds doctors use to look inside your organs. Foreign CEOs are rare in Japan.
Florida surgeon general: This is the bottom line on COVID-19 booster vaccines
Florida Surgeon General Dr. Joseph Ladapo analyzes Moderna CEO Stephane Bancel's claim that younger individuals might not need annual COVID-19 boosters on 'The Evening Edit.'
FDA authorizes Novavax COVID booster for adults
The Food and Drug Administration authorized the Novavax COVID-19 vaccine as a booster for use in adults on Wednesday. The company has struggled with vaccine sales.
Johnson & Johnson beats sales estimates on pharma strength
The company tightened its full-year adjusted profit forecast range. Sales at its medical devices unit rose to $6.78 billion on demand for contact lenses and wound-closure products.
Walmart, CVS, Walgreens start selling over-the-counter hearing aids: What to know
Retailers started selling over-the-counter hearing aids nationwide this week, giving Americans with perceived mild-to-moderate hearing impairments better access to products.
Elon Musk jumps on new weight-loss trend: diabetic medications
Many people, including buisness magnate Elon Musk, have used a drug known as Wegovy to shed some weight or jumpstart their weight loss. Although it can be pricy.
Advances in breast cancer detection, treatment have dropped death rates
Mount Sinai Chief of Breast Surgery Dr. Elisa Port raises awareness for breast cancer and discusses how technology has become better to prevent and treat it on 'Mornings with Maria.'
Walgreens says staffing shortages hit prescription growth
Walgreens Boots Alliance executives said during their earnings call Thursday that pharmacy staffing shortages have created challenges for prescription growth.
CVS in exclusive talks to acquire Cano Health: report
Shares of Cano Health climbed on Friday following a report the value-based primary care provider is in exclusive talks to be bought by CVS Health. The Miami-based healthcare provider went public in June 2021.
Fitbit users will be required to log in through Google by 2025
Google will require new and existing Fitbit users to sign in through its services to access Fitbit accounts by 2025. Google bought Fitbit in January 2021.
Zero-premium Medicare Advantage plans: What to know
Zero-premium Medicare Advantage plans are popular, but not all coverage is the same. Here's what shoppers should know ahead of next week's enrollment.
FDA approves Amylyx ALS drug
Amylyx says doctors will be able to prescribe Relyvrio immediately. The drugmaker anticipates prescriptions will be filled and shipped from specialty pharmacies within the next four to six weeks.
Amazon to release Halo Rise later this year: A bedside alarm clock and sleep tracking device
Amazon has announced the new Halo Rise, a no-contact sleep tracking device that is set to release later this year. The device doubles as an alarm clock.
Biogen's new Alzheimer's drug could take 'some time' to reach Medicare market: Laura Chico
Wedbush Securities Senior Vice President of biotech equity research Laura Chico says questions remain about the benefits and risks of Biogen's experimental Alzheimer's drug.
Medical streaming service combines tech and entertainment to make health information accessible to everyone
Dr. Stephen O'Brien, chief medical officer of Mediflix, shares how his streaming platform is trailblazing access to medical information for everyone.
Grove's CVS deal proves zero waste trend plays in the big market: Stuart Landesberg
Grove Collaborative CEO Stuart Landesberg discusses the company's mission and partnership with CVS stores across the U.S. on 'The Claman Countdown.'